Deep Brain Stimulation
91
32
36
20
Key Insights
Highlights
Success Rate
77% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.6%
6 terminated out of 91 trials
76.9%
-9.6% vs benchmark
2%
2 trials in Phase 3/4
30%
6 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (91)
Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting
A Study of Buntanetap in Participants With PD
Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease
Udall Project 1 Aim 4
A Multicenter Pediatric Deep Brain Stimulation Registry
Coordinated Reset Deep Brain Stimulation for Parkinson's Disease
Sleep-specific DBS Therapy in Parkinson's Disease
Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS
Use of CereGate Therapy for Freezing of Gait in PD
Predictors of Clinical Outcomes of Deep Brain Stimulation in Parkinson's Disease
LIFUS For Neurological Disorders
Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Comparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar Programming
Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease
Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia
The Impact of Exercise on Subthalamic Nucleus Neural Activity in Parkinson's Disease
Cortical Network Modulation by Subthalamic Nucleus DBS
Revision of Deep Brain Stimulator in Patients With Parkinson's Disease
Effect of Mediterranean Diet on Nutrition in Parkinson's Disease Patients With Bilateral Subthalamic Deep Brain Stimulation
Utilizing Neural Signatures and Virtual Reality to Advance DBS Programming